Replies to post #1120 on Alaunos Therapeutics Inc (TCRT)

[jondoeuk]

We know about the product, they are going to target more neoantigens, working on 'next gen' versions (likely multiplex editing) [1], addressing manufacturing and should have dosed the first patient. If you have info on all this when it comes to ZIOP then do share it.

Ref:
1 (data from CRSP) https://crisprtx.gcs-web.com/static-files/8ea0746a-7aaf-4350-a451-db66efa26f6b